News and Events| Thermo Fisher Scientific Launches New Biomarker Test in Europe to Rapidly Diagnose Heart Attack | | WALTHAM, Mass.--(BUSINESS WIRE)--Oct. 26, 2009--
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving
science, today announced the availability in Europe of its new Copeptin
assay, which helps medical personnel quickly and accurately diagnose
acute myocardial infarction (AMI), commonly known as a heart attack.
Copeptin, developed by recently acquired B.R.A.H.M.S. AG, is a patented
biomarker for AMI and is detectible using a simple b... More >> |
Recent Press Releases |  | Media contact:
Karen Kirkwood
+ 1 781 622 1306
Investor contact:
Ken Apicerno
+ 1 781 622 1111 |